ImQuest BioSciences is a preclinical contract research and development organization (CRO) that provides services to evaluate the potential of new and novel pharmaceutical products for the treatment and prevention of viruses, bacteria, cancer and inflammatory diseases. As part of our ImQuest SUCCESS platform, we provide expert preclinical research services, including compound screening to define compound efficacy and drug target validation analysis to define the mechanism of action and toxicity of pharmaceutical products. We specialize in the development of small molecules, natural products, biologics, antimicrobial peptides, therapeutic antibodies and vaccines for infectious disease and cancer drug development programs. Our preclinical contract research services are comprised of interrelated efficacy-defining components for infectious disease (including microbiology and virology), cancer and women's health with parallel evaluations of in vitro and ex vivo toxicity and the pharmaceutical properties and chemical structure of preclinical candidates to efficiently validate you drug target. We are committed to earning our client's trust and building long term relationships through collaboration, unwavering commitment to quality science and consistent and effective communication. Our team has decades of experience in the field of virology, microbiology and oncology. As such, we understand that each product and each client is unique and we strive to provide effective solutions.
View Top Employees from ImQuest BioSciencesWebsite | http://imquestbio.com |
Revenue | $6 million |
Employees | 15 (15 on RocketReach) |
Founded | 2004 |
Address | 7340 Executive Way Suite R, Frederick, Maryland 21704, US |
Phone | (301) 696-0274 |
Fax | (301) 696-0381 |
Technologies |
JavaScript,
HTML,
PHP
+11 more
(view full list)
|
Industry | Biotechnology Research, Business Services General, Virology, Business Services, Microbiology, Preclinical Contract Research, Toxicology, Topical Microbicides, Product Formulation, Immunology and Flow Cytometry, Molecular Biology Services, Biochemistry Services, Grant Writing |
Web Rank | 30 Million |
Keywords | Biofilm Formation Protocol |
Competitors | Alios BioPharma, Cancer Prevention Pharmaceuticals, Inc, OBI Pharma, Inc, Olon Ricerca Bioscience, Plato BioPharma, Inc. |
SIC | SIC Code 87 Companies, SIC Code 873 Companies |
NAICS | NAICS Code 54 Companies, NAICS Code 5417 Companies, NAICS Code 541 Companies, NAICS Code 541714 Companies, NAICS Code 54171 Companies |
Looking for a particular ImQuest BioSciences employee's phone or email?
The ImQuest BioSciences annual revenue was $6 million in 2024.
Robert Buckheit is the COO of ImQuest BioSciences.
15 people are employed at ImQuest BioSciences.
ImQuest BioSciences is based in Frederick, Maryland.
The NAICS codes for ImQuest BioSciences are [54, 5417, 541, 541714, 54171].
The SIC codes for ImQuest BioSciences are [87, 873].